These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 8394502

  • 21. No response improvement after sequential chemotherapy for small cell lung cancer.
    Postmus PE, Sleijfer DT, Meinesz AF, Kerstjens HA, Lo GT, Sluiter HJ.
    Eur J Respir Dis; 1986 Apr; 68(4):279-85. PubMed ID: 3015648
    [Abstract] [Full Text] [Related]

  • 22. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K, Pan Z, Wood ME, Murphy J, Bunn PA.
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [Abstract] [Full Text] [Related]

  • 23. Etoposide (VP-16) containing combination chemotherapy for treatment of patients with small cell lung cancer.
    Behera D, Jindal SK, Sharma SC.
    Indian J Chest Dis Allied Sci; 1995 Nov; 37(1):15-9. PubMed ID: 16892733
    [Abstract] [Full Text] [Related]

  • 24. [Treatment of lung cancer--state of the art in 2000].
    Nakanishi Y, Inoue K, Hara N.
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023
    [Abstract] [Full Text] [Related]

  • 25. [Induction chemotherapy followed by adjuvant surgery (IC-AS) in patients with stage I-II small cell lung cancer (SCLC)].
    Shibayama T, Hiyama J, Ueoka H, Tabata M, Segawa Y, Gemba K, Matsushita A, Ohnoshi T, Harada M, Andoh A.
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1953-8. PubMed ID: 7487126
    [Abstract] [Full Text] [Related]

  • 26. Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma: a phase II trial of the North Central Cancer Treatment Group.
    Jett JR, Hatfield AK, Hillman S, Bauman MD, Mailliard JA, Kugler JW, Morton RF, Marks RS, Levitt R.
    Cancer; 2003 May 15; 97(10):2498-503. PubMed ID: 12733149
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Combination versus alternating chemotherapy in small-cell lung cancer.
    Lai SL, Perng RP.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul 15; 63(7):513-20. PubMed ID: 10934803
    [Abstract] [Full Text] [Related]

  • 29. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R, Cetinayak HO, Sen RC, Demiral AN, Akkoçlu A, Osma E, Kargi A, Oztop I, Onen A, Kinay M, Dokuz Eylül Lung Cancer Study Group.
    J BUON; 2006 Jul 15; 11(1):31-7. PubMed ID: 17318949
    [Abstract] [Full Text] [Related]

  • 30. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG, James LE, Rudd RM, Trask CW, Tobias JS, Snee M, Gilligan D, Murray PA, Ruiz de Elvira MC, O'Donnell KM, Gower NH, Harper PG, Hackshaw AK, London Lung Cancer Group.
    J Clin Oncol; 2006 Aug 20; 24(24):3823-30. PubMed ID: 16921033
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
    Kakolyris S, Agelidou A, Androulakis N, Tsaroucha E, Kouroussis Ch, Agelidou M, Karvounis N, Veslemes M, Christophylakis Ch, Argyraki A, Geroyianni A, Georgoulias V.
    Lung Cancer; 2006 Jul 20; 53(1):59-65. PubMed ID: 16716447
    [Abstract] [Full Text] [Related]

  • 33. European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.
    Ardizzoni A, Manegold C, Debruyne C, Gaafar R, Buchholz E, Smit EF, Lianes P, ten Velde G, Bosquee L, Legrand C, Neumaier C, King K, Giuseppe giaccone European organization for research and treatment of cancer (EORTC) lung cancer group.
    Clin Cancer Res; 2003 Jan 20; 9(1):143-50. PubMed ID: 12538462
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Randomized comparative study of CE (CDDP plus etoposide) and CE-AVN (ACNU, VCR plus procarbazine) as combined anticancer chemotherapy in small cell cancer of the lung].
    Kinoshita S, Bandou H, Yamashita T, Fukuta K, Yamasaki K, Matsuura A, Shimizu E, Ogura T, Doi H, Nakamura T.
    Gan To Kagaku Ryoho; 1988 Apr 20; 15(4 Pt 1):643-8. PubMed ID: 2833178
    [Abstract] [Full Text] [Related]

  • 36. [Cyclic alternating combination chemotherapy of small cell carcinoma of the lung].
    Urata A, Ota K, Nishimura M, Sugiura T, Yamamoto N.
    Gan To Kagaku Ryoho; 1986 Feb 20; 13(2):286-92. PubMed ID: 3004365
    [Abstract] [Full Text] [Related]

  • 37. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
    Lindgren D, Cadman E, Erichson R, Grann V, Sachs K.
    Cancer Treat Rep; 1984 Sep 20; 68(9):1159-61. PubMed ID: 6090015
    [Abstract] [Full Text] [Related]

  • 38. [The role of surgical treatment in the combination therapy of small cell lung cancer (SCLC)].
    Yamaguchi Y, Momiki S, Kimura H, Ogawa T, Baba M.
    Kyobu Geka; 1988 Mar 20; 41(3):184-9. PubMed ID: 2838669
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Patient with extensive small cell lung cancer given moderately dose-intensified chemotherapy and peripheral blood stem cell support.
    Shimizu E, Takaue Y, Yamamoto A, Ogura T, Sone S.
    Jpn J Clin Oncol; 1995 Oct 20; 25(5):213-7. PubMed ID: 7474410
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.